AIG
CARM

American International Group’s Carisma Therapeutics CARM Stock Holding History

American International Group’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,140
Closed -$29.8K – 451
2024
Q1 		$29.8K Sell
13,140
-113
-0.9% -$271 ﹤0.01% 2880
2023
Q4 		$38.8K Sell
13,253
-54
-0.4% -$161 ﹤0.01% 2868
2023
Q3 		$56.3K Buy
13,307
+473
+4% +$2.99K ﹤0.01% 2785
2023
Q2 		$113K Buy
+12,834
New +$69.9K ﹤0.01% 2500
2022
Q2 		– Sell
-4,997
Closed -$60K – 3116
2022
Q1 		$60K Sell
4,997
-352
-7% -$4.92K ﹤0.01% 2786
2021
Q4 		$87K Sell
5,349
-65
-1% -$1.31K ﹤0.01% 2775
2021
Q3 		$86K Buy
5,414
+624
+13% +$29.9K ﹤0.01% 2853
2021
Q2 		$443 Buy
+4,790
New +$305K ﹤0.01% 1994
2016
Q2 		– Sell
-13
Closed – – 3225
2016
Q1 		$0 Hold
13
– – ﹤0.01% 5033
2015
Q4 		$1K Hold
13
– – ﹤0.01% 4908
2015
Q3 		$1K Hold
13
– – ﹤0.01% 4882
2015
Q2 		$705 Sell
13
-144
-92% -$20.3K ﹤0.01% 5003
2015
Q1 		$27.9K Hold
157
– – ﹤0.01% 4220
2014
Q4 		$37.2K Sell
157
-5
-3% -$1.12K ﹤0.01% 4087
2014
Q3 		$36.1K Buy
162
+12
+8% +$2.85K ﹤0.01% 4102
2014
Q2 		$39.5K Buy
+150
New +$37.1K ﹤0.01% 4038

Other funds holding CARM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American International Group's CARM Position: Q2 2024 in Review

American International Group sold out of Carisma Therapeutics (CARM) in Q2 2024, closing a stake of 13,140 shares — an estimated $29.8K sold.

American International Group first reported a position in CARM in Q2 2014 and held it in 16 quarters. The position peaked at $113K in Q2 2023. 53 funds tracked by Wall St. Rank hold CARM as of Q2 2024.

  • American International Group reported no remaining Carisma Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 13,140 Carisma Therapeutics shares in Q2 2024, an estimated $29.8K.
  • American International Group first reported a position in Carisma Therapeutics in Q2 2014 and held it in 16 quarters.
  • American International Group's Carisma Therapeutics position peaked at $113K in Q2 2023.
  • 53 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.